Bayer applies for Regorafenib authorisation to treat liver cancer

FRANKFURT, Nov 7 (Reuters) - German drugmaker Bayer

on Monday said it submitted an application to have

its cancer drug Regorafenib approved for the second-line

treatment of liver cancer patients...

Read more